
Results 1 - 15 of 15 in Diovan, Valsartan (generic)
Updated European guidelines highlight benefits of Rasilez, the only...
Rasilez, a first-in-class direct renin inhibitor , works at the point of activation of the renin angiotensin aldosterone system , directly inhibiting the activity of renin, an enzyme that triggers a process that may lead to high blood pressure and organ damage2,3. The updated European Guidelines on Hypertension Management, appraised by an ESH task ... Comment?
Novartis Receives Approval in the European Union for Exforge HCTA
Basel, - The European Commission has granted Novartis marketing authorization for Exforge HCT , a new 3-in-1 treatment for people with high blood pressure. Comment?
Research and Markets: Key Attractions of the Malaysian Pharmaceutical ...
Research and Markets: Key Attractions of the Malaysian Pharmaceutical Market Are the Government's Encouragement of the Biotechnology Sector Says This Q4 2009 Report The Malaysia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and ... Comment?
Waiting for New Novartis HBP Drug
Novartis is expected to launch its high blood pressure drug Valturna shortly after the recent US Food and Drug Administration approval. Comment?
Snapshot Report ) Valturna for high blood pressure. The drug is a single-pill combination of Diovan , an angiotensin receptor blocker, and Tekturna , the only approved direct renin inhibitor. Comment?
Novartis gets FDA Approval for Blood Pressure Drug
The drug is a single-pill combination of valsartan and aliskiren. Valsartan is the active ingredient in Novartis' high blood pressure drug Diovan while aliskiren is the active ingredient in the company's blood pressure drug Tekturna. Comment?
Novartis Gains Approval for Valturna Combo
The FDA has approved Novartis ' Valturna tablets, a medicine targeting two key points within the renin system, also known as the renin angiotensin aldosterone system , a regulator of blood pressure. Comment?
Novartis Corporation Receives FDA Approval for Valturna(R), a...
The US Food and Drug Administration has approved Valturna tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system , an important regulator of blood pressure. Comment?
Novartis Receives FDA Approval For Valturna(R), A Single-Pill...
Main Category: Hypertension Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 18 Sep 2009 - 2:00 PDT The US Food and Drug Administration has approved Valturna ) tablets, the first and only medicine to target two key points within the renin system, also known as ... Comment?
Novartis Receives FDA Approval For Valturna , A Single-Pill...
September 18, 2009 Valturna combines in a single pill valsartan, an angiotensin receptor blocker, with aliskiren, the only approved direct renin inhibitor Valturna is the first therapy to target two points within the renin angiotensin aldosterone system , which plays a key role in regulating blood pressure Valturna offers significantly greater ... Comment?
Good news for Asian Canadians with uncontrolled hypertension
A total of 3,031 Japanese patients with uncontrolled high blood pressure either with no treatment or on a previous non-ARB-based regimen and with one or more pre-defined cardiovascular risk factors took part in the study. Comment?
Research and Markets: Forecast Insight: Antihypertensives New Fixed...
Following the patent expiries of ARBs Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008. Comment?
In Heart Failure Patients Treated With ACE Inhibitor And/or Beta...
Main Category: Cardiovascular / Cardiology Also Included In: Heart Disease Article Date: 02 Sep 2009 - 2:00 PDT Data confirm that in heart failure patients being treated with ACE inhibitor and/or beta blocker, higher plasma renin activity still predicts greater risk of mortality1. Comment?
New Data Confirm That Diovan(R) And Valsartan-Based Combinations...
Data presented at the 19th Scientific Meeting of the European Society of Hypertension confirm that Diovan and valsartan-based combinations deliver sustained, 24-hr blood pressure -lowering efficacy2-6. Studies have suggested that the relative risks of acute myocardial infarction, stroke and sudden cardiac death are 40%, 49% and 29% higher, ... Comment?
New Data Confirm That Diovan(R) And Valsartan-Based Combinations...
Data presented at the 19th Scientific Meeting of the European Society of Hypertension confirm that Diovan and valsartan-based combinations deliver sustained, 24-hr blood pressure -lowering efficacy2-6. Studies have suggested that the relative risks of acute myocardial infarction, stroke and sudden cardiac death are 40%, 49% and 29% higher, ... Comment?